EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
13.08.24
/
50%
€7.68
Target price
13.08.25
€26.50
Performance (%)
18.65%
End price
14.08.25
€9.11
Summary
This prediction ended on 14.08.25 with a price of €9.11. The BUY prediction by JPMorgan_Chase___Co_ finished with a performance of 18.65%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -0.826% | -0.826% | 53.257% |
| iShares Core DAX® | 1.770% | 3.450% | 5.562% |
| iShares Nasdaq 100 | -3.500% | 1.607% | 32.311% |
| iShares Nikkei 225® | -4.942% | 4.221% | 57.828% |
| iShares S&P 500 | 0.300% | 2.580% | 24.810% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.46
04.06.24
04.06.24
€29.43
04.06.25
04.06.25
-15.94%
05.06.25
05.06.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.60
22.01.24
22.01.24
€32.12
22.01.25
22.01.25
-61.75%
23.01.25
23.01.25